Showing 9 of 9 results
- CRISPR disruption screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 240 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- CRISPR disruption screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 80 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- CRISPR interference screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 80 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- Control CRISPR screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transductionLab: Yin Shen, UCSFProject: ENCODE
- Control CRISPR screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transductionLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE